| AAI | aristolochic acid I |
| AAN | aristolochic acid nephropathy |
| BEN | Balkan endemic nephropathy |
| BRCA | breast cancer susceptibility gene |
| bw | body weight |
| CDK | cyclin-dependent kinase |
| CYP | cytochrome P450 |
| EMT | epithelial-to-mesenchymal transition |
| FDR | false discovery rate |
| GLUT | glucose transporter |
| HIF-1 | hypoxia-inducible factor 1 |
| Hupki | human TP53 knock-in |
| i.p. | intraperitoneal |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NGAL or LCN2 | neutrophil gelatinase-associated lipocalin |
| NQO | NAD(P)H:quinone oxidoreductase |
| OAT | organic anion transporter |
| p | p-value |
| p21Cip1/Waf1 or CDKN1A | cyclin-dependent kinase inhibitor 1a |
| p53 | tumour protein p53 |
| QC | quality control |
| SLC | solute carrier |
| TP53 | tumour protein 53 gene (human) |
| Trp53 | tumour protein 53 gene (mouse) |